Cohen, M. G., Vavalle, J. P., Buller, C. E., Ebelt, H., Montalescot, G., Povsic, T. J., … Mehran, R. (2011). Access and non-Access Site Bleeding in Acute Coronary Syndrome Patients Treated with a Novel Actively Reversible Factor IXa Inhibitor. Results from the RADAR Trial. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 58, pp. B47–B47). San Francisco, CA: ELSEVIER SCIENCE INC.

Cohen, Mauricio G., John P. Vavalle, Christopher E. Buller, Henning Ebelt, Gilles Montalescot, Thomas J. Povsic, Jan H. Cornel, et al. “Access and non-Access Site Bleeding in Acute Coronary Syndrome Patients Treated with a Novel Actively Reversible Factor IXa Inhibitor. Results from the RADAR Trial.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 58:B47–B47. ELSEVIER SCIENCE INC, 2011.

Cohen MG, Vavalle JP, Buller CE, Ebelt H, Montalescot G, Povsic TJ, et al. Access and non-Access Site Bleeding in Acute Coronary Syndrome Patients Treated with a Novel Actively Reversible Factor IXa Inhibitor. Results from the RADAR Trial. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2011. p. B47–B47.

Cohen, Mauricio G., et al. “Access and non-Access Site Bleeding in Acute Coronary Syndrome Patients Treated with a Novel Actively Reversible Factor IXa Inhibitor. Results from the RADAR Trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 58, no. 20, ELSEVIER SCIENCE INC, 2011, pp. B47–B47.

Cohen MG, Vavalle JP, Buller CE, Ebelt H, Montalescot G, Povsic TJ, Cornel JH, Bode C, Fail P, Kasprzak JD, Zelenkofske SL, Alexander JH, Becker RC, Mehran R. Access and non-Access Site Bleeding in Acute Coronary Syndrome Patients Treated with a Novel Actively Reversible Factor IXa Inhibitor. Results from the RADAR Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2011. p. B47–B47.